Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
- 1 July 2006
- journal article
- other
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 174 (1) , 6-14
Abstract
There has been increasing interest in using pulmonary biomarkers to understand and monitor the inflammation in the respiratory tract of patients with chronic obstructive pulmonary disease (COPD). In this Pulmonary Perspective we discuss the merits of the various approaches by reviewing the current literature on pulmonary biomarkers in COPD and underscore the need for more systematic studies in the future. Bronchial biopsies and bronchoalveolar lavage provide valuable information about inflammatory cells and mediators, but are invasive, so that repeated measurements have to be very limited in assessing any interventions. Induced sputum has provided considerable information about the inflammatory process, including mediators and proteinases in COPD, but selectively samples proximal airways and may not closely reflect distal inflammatory processes. Exhaled gases and breath condensate are noninvasive procedures, so repeated measurements are possible, but for some assays the variability is relatively high. There is relatively little information about how any of these biomarkers relate to other clinical outcomes, such as progression of the disease, severity of disease, clinical subtypes, or response to therapy. More information is also needed about the variability in these measurements. In the future, pulmonary biomarkers may be useful in predicting disease progression, indicating disease instability, and in predicting response to current therapies and novel therapies, many of which are now in development.Keywords
This publication has 140 references indexed in Scilit:
- Elevated MMP-12 protein levels in induced sputum from patients with COPDThorax, 2006
- Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2005
- Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysemaEuropean Respiratory Journal, 2005
- Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammationThorax, 2004
- The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammationEuropean Respiratory Journal, 2004
- Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPDThorax, 2003
- Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPDEuropean Respiratory Journal, 2002
- Biomarkers of some pulmonary diseases in exhaled breathBiomarkers, 2002
- Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary diseaseThorax, 1998